Shares of MetLife, Inc. (NYSE:MET – Get Free Report) have earned an average recommendation of “Buy” from the thirteen analysts that are currently covering the company, MarketBeat Ratings reports. Thirteen research analysts have rated the stock with a buy recommendation. The average 1 year target price among brokers that have updated their coverage on the stock in the last year is $88.46.
Several equities analysts recently commented on the company. Bank of America reduced their target price on MetLife from $99.00 to $96.00 and set a “buy” rating for the company in a research report on Thursday, August 1st. TD Cowen assumed coverage on shares of MetLife in a research note on Wednesday, October 9th. They issued a “buy” rating and a $97.00 target price on the stock. JPMorgan Chase & Co. boosted their price target on shares of MetLife from $81.00 to $86.00 and gave the stock an “overweight” rating in a research note on Tuesday, July 2nd. Morgan Stanley lowered their price objective on shares of MetLife from $86.00 to $85.00 and set an “overweight” rating on the stock in a research report on Monday, August 19th. Finally, Barclays started coverage on shares of MetLife in a research report on Wednesday, September 4th. They issued an “overweight” rating and a $91.00 target price for the company.
Check Out Our Latest Analysis on MetLife
Institutional Investors Weigh In On MetLife
MetLife Trading Down 0.1 %
Shares of MET opened at $84.77 on Friday. MetLife has a twelve month low of $57.91 and a twelve month high of $86.94. The stock has a market cap of $60.28 billion, a PE ratio of 29.13, a P/E/G ratio of 0.69 and a beta of 1.04. The company has a quick ratio of 0.16, a current ratio of 0.16 and a debt-to-equity ratio of 0.56. The business’s 50-day moving average price is $79.11 and its 200-day moving average price is $74.29.
MetLife (NYSE:MET – Get Free Report) last posted its earnings results on Wednesday, July 31st. The financial services provider reported $2.28 earnings per share for the quarter, topping analysts’ consensus estimates of $2.13 by $0.15. The business had revenue of $17.82 billion for the quarter, compared to analyst estimates of $18.57 billion. MetLife had a net margin of 4.23% and a return on equity of 21.41%. MetLife’s revenue was up 7.2% on a year-over-year basis. During the same quarter in the prior year, the firm posted $1.94 EPS. On average, equities analysts forecast that MetLife will post 8.61 EPS for the current fiscal year.
MetLife Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Monday, December 16th. Stockholders of record on Tuesday, November 5th will be paid a dividend of $0.545 per share. This represents a $2.18 dividend on an annualized basis and a dividend yield of 2.57%. The ex-dividend date is Tuesday, November 5th. MetLife’s dividend payout ratio (DPR) is presently 74.91%.
About MetLife
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
Featured Articles
- Five stocks we like better than MetLife
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- How Verizon Could Offer Stress-Free Double-Digit Returns in 2025
- What Are Dividend Achievers? An Introduction
- Can Roche Challenge Lilly and Novo in the Weight Loss Market?
- With Risk Tolerance, One Size Does Not Fit All
- Roblox Stock: Key Metrics Surge, Is This the Perfect Entry?
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.